Cambridge-based medical devices company receives £130,000 funding

Investment

CAMBfix, the orthopaedic medical device company based in Cambridge, UK, has received £65,000 funding from Cambridge Enterprise Seed Funds and £65,000 from North East Equity Matching Limited.

CAMBfix, founded in 2004 by two University of Cambridge alumni, develops innovative medical equipment for use in orthopaedic and trauma surgery. The company has employed its platform technology for the treatment of broken bones in its first product, a fixator for wrist fractures that allows for movement of the joint during the course of treatment.

Dr Ali Bajwa, a trauma and orthopaedic surgeon, research scientist and CAMBfix founder, said: “This new method of treating fractures will result in treatment without the need for an open operation ensuring early rehabilitation, and reducing the chances of infection and physiotherapy needs. It can also potentially be used in the field and is likely to prove invaluable for military and sports uses outside of established clinics improving care in environments with limited skills and resources.”

Dr Anne Dobrée, Investment Manager at Cambridge Enterprise Seed Funds, said: “The current practice of treating fractures can result in about one third of the cases developing a complication such as infection, stiffness, loss of fracture position and this leads to greater costs to the healthcare industry. The CAMBfix platform technology is not just good news for the patients but also will reduce healthcare industry costs related to fractures”.